Godrej Agrovet (GODREJAGRO) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
8 Jul, 2026Executive summary
Q3 FY26 saw consolidated revenues grow 11% year-over-year to ₹2,718 crore, with profit before tax up 23% and EBITDA growth of 25%, driven by margin expansion, operational efficiencies, and strong segment contributions.
Nine-month consolidated revenues reached ₹7,900 crore, up 9% year-over-year; profit before tax (excluding exceptional items) rose 17% to ₹482 crore.
Unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, were approved, with limited review reports carrying unmodified opinions.
Financial statements prepared in accordance with Ind-AS and reviewed by statutory auditors.
Animal Feed and Vegetable Oil segments delivered robust volume and margin growth, while Dairy and Crop Protection faced headwinds from higher input costs and adverse weather.
Financial highlights
Q3 FY26 consolidated revenue was ₹2,718 crore, up 11% year-over-year; EBITDA was ₹260 crore, up 13.6%; PBT before non-recurring items was ₹169 crore, up 23.1%.
PAT before non-recurring items grew 33.9% to ₹133 crore; EBITDA margin improved to 9.6%.
For 9M FY26, revenue rose 9% to ₹7,900 crore, EBITDA up 8.9% to ₹763 crore, and PBT up 13.2% to ₹482 crore.
Animal Feed segment volumes up 12% year-over-year in Q3; cattle feed volumes surged 21%.
Vegetable Oil segment revenue up 27% year-over-year, with segment results up 25%.
Outlook and guidance
Astec LifeSciences targets 15% revenue growth in FY27, with CDMO expected to lead growth and margins to improve as demand stabilizes.
Crop Protection expects healthy growth ex-co-marketing impact in Q4, with new product launches and diversification underway.
Oil Palm business expects FFB tonnage growth in the 12%-15% CAGR range, supported by acreage expansion and demographic dividend.
Foods business to focus on branded retail, aiming for continued margin expansion and innovation.
Continued focus on margin expansion, operational efficiency, and new product development is expected to drive future growth.
Latest events from Godrej Agrovet
- Profitability and margins rose in FY25 despite lower revenue, with key acquisitions and dividend.GODREJAGRO
Q4 24/258 Jul 2026 - Q1 FY26 delivered double-digit revenue and profit growth, led by Vegetable Oil and Astec LifeSciences.GODREJAGRO
Q1 25/2619 Jun 2026 - Profit and margins surged in Q1 FY25; new feed plant and Tyson Foods acquisition approved.GODREJAGRO
Q1 24/2519 Jun 2026 - FY26 revenue hit INR 10,233 crore with strong profit, margin gains, and a Rs. 11 dividend.GODREJAGRO
Q4 25/264 May 2026 - Q3 FY25 profit and margins rose, led by Animal Feed and Vegetable Oil; borrowing plan deferred.GODREJAGRO
Q3 24/253 Feb 2026 - Profit and margin gains offset revenue drop; full Godrej Tyson Foods ownership and ESG progress.GODREJAGRO
Q2 24/2518 Jan 2026 - H1 FY26 revenue up 8% with strong Animal Feed and Vegetable Oil, but Crop Protection lagged.GODREJAGRO
Q2 25/2613 Nov 2025